Acorah Software Products - Accounts Production15.0.600falsetrue31 January 20231 February 2022falsetrueNo description of principal activity1 February 202331 January 202431 January 202413812597Miss Ansa Akhtariso4217:GBPiso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:pure138125972023-01-31138125972024-01-31138125972023-02-012024-01-3113812597frs-core:CurrentFinancialInstruments2024-01-3113812597frs-bus:PrivateLimitedCompanyLtd2023-02-012024-01-3113812597frs-bus:FilletedAccounts2023-02-012024-01-3113812597frs-bus:Micro-entities2023-02-012024-01-3113812597frs-bus:AuditExempt-NoAccountantsReport2023-02-012024-01-3113812597frs-bus:Director12023-02-012024-01-31138125972022-01-31138125972023-01-31138125972022-02-012023-01-3113812597frs-core:CurrentFinancialInstruments2023-01-31
Registered number: 13812597
Aa Pharmaceuticals Ltd
Unaudited Financial Statements
For The Year Ended 31 January 2024
Aa Pharmaceuticals Ltd
Balance Sheet
As At 31 January 2024
Balance Sheet
Registered number: 13812597
2024
2023
£
£
Current assets
8,010
6,250
Creditors: Amounts Falling Due Within One Year
(2,319)
(4,363)
NET CURRENT ASSETS
5,691
1,887
TOTAL ASSETS LESS CURRENT LIABILITIES
5,691
1,887
NET ASSETS
5,691
1,887
CAPITAL AND RESERVES
5,691
1,887
Notes
1.General Information
Aa Pharmaceuticals Ltd is a private company, limited by shares, incorporated in , registered number 13812597. The registered office is 1 Dodgson Road, Oxford, OX4 3QS.
2.Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2023: 1)
11
For the year ending 31 January 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.